Titre : Phytophthora

Phytophthora : Questions médicales fréquentes

Termes MeSH sélectionnés :

Probability
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Phytophthora : Questions médicales les plus fréquentes", "headline": "Phytophthora : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Phytophthora : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-18", "dateModified": "2025-02-12", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Phytophthora" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oomycetes", "url": "https://questionsmedicales.fr/mesh/D009868", "about": { "@type": "MedicalCondition", "name": "Oomycetes", "code": { "@type": "MedicalCode", "code": "D009868", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.750.580" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Phytophthora infestans", "alternateName": "Phytophthora infestans", "url": "https://questionsmedicales.fr/mesh/D055750", "about": { "@type": "MedicalCondition", "name": "Phytophthora infestans", "code": { "@type": "MedicalCode", "code": "D055750", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B01.750.580.715.600" } } } ], "about": { "@type": "MedicalCondition", "name": "Phytophthora", "alternateName": "Phytophthora", "code": { "@type": "MedicalCode", "code": "D010838", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Altino Choupina", "url": "https://questionsmedicales.fr/author/Altino%20Choupina", "affiliation": { "@type": "Organization", "name": "Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253, Bragança, Portugal. albracho@ipb.pt." } }, { "@type": "Person", "name": "Guohong Cai", "url": "https://questionsmedicales.fr/author/Guohong%20Cai", "affiliation": { "@type": "Organization", "name": "Crop Production and Pest Control Research Unit, Agricultural Research Service, USDA, and College of Agriculture, Purdue University, West Lafayette, Indiana, United States of America." } }, { "@type": "Person", "name": "Iuliia Branco", "url": "https://questionsmedicales.fr/author/Iuliia%20Branco", "affiliation": { "@type": "Organization", "name": "Centro de Investigação de Montanha (CIMO), Instituto Politécnico de Bragança, Campus de Santa Apolónia, 5300-253, Bragança, Portugal." } }, { "@type": "Person", "name": "Jun Meng", "url": "https://questionsmedicales.fr/author/Jun%20Meng", "affiliation": { "@type": "Organization", "name": "School of Computer Science and Technology, Dalian University of Technology, Dalian 116024, China." } }, { "@type": "Person", "name": "Stephen C Whisson", "url": "https://questionsmedicales.fr/author/Stephen%20C%20Whisson", "affiliation": { "@type": "Organization", "name": "Cell and Molecular Sciences, James Hutton Institute, Invergowrie, Dundee DD2 5DA, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis.", "datePublished": "2024-05-07", "url": "https://questionsmedicales.fr/article/38774215", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fphar.2024.1336347" } }, { "@type": "ScholarlyArticle", "name": "Cluster-Based Toxicity Estimation of Osteoradionecrosis via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification.", "datePublished": "2023-03-29", "url": "https://questionsmedicales.fr/article/37034700", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1101/2023.03.24.23287710" } }, { "@type": "ScholarlyArticle", "name": "Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).", "datePublished": "2022-07-01", "url": "https://questionsmedicales.fr/article/35834254", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1001/jamanetworkopen.2022.20680" } }, { "@type": "ScholarlyArticle", "name": "Dependent censoring bias assessment using inverse probability of censoring weights: Type 2 diabetes mellitus risk in patients initiating bisoprolol versus other antihypertensives in a Clinical Practice Research Datalink cohort study.", "datePublished": "2024-11-17", "url": "https://questionsmedicales.fr/article/39417364", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.57264/cer-2023-0027" } }, { "@type": "ScholarlyArticle", "name": "Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance.", "datePublished": "2023-03-04", "url": "https://questionsmedicales.fr/article/36880088", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1093/jacamr/dlad011" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Eucaryotes", "item": "https://questionsmedicales.fr/mesh/D056890" }, { "@type": "ListItem", "position": 3, "name": "Straménopiles", "item": "https://questionsmedicales.fr/mesh/D058009" }, { "@type": "ListItem", "position": 4, "name": "Oomycetes", "item": "https://questionsmedicales.fr/mesh/D009868" }, { "@type": "ListItem", "position": 5, "name": "Phytophthora", "item": "https://questionsmedicales.fr/mesh/D010838" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Phytophthora - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Phytophthora", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Phytophthora", "description": "Comment diagnostiquer une infection par Phytophthora ?\nQuels tests de laboratoire sont utilisés ?\nQuels symptômes indiquent une infection ?\nPeut-on confondre Phytophthora avec d'autres champignons ?\nQuel rôle joue l'humidité dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D010838?mesh_terms=Probability&page=275#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Phytophthora", "description": "Quels sont les symptômes courants de Phytophthora ?\nComment se manifeste la pourriture des racines ?\nLes fruits peuvent-ils être affectés ?\nLes symptômes varient-ils selon les plantes ?\nY a-t-il des signes visibles sur le sol ?", "url": "https://questionsmedicales.fr/mesh/D010838?mesh_terms=Probability&page=275#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Phytophthora", "description": "Comment prévenir les infections par Phytophthora ?\nQuel rôle joue le drainage dans la prévention ?\nLes variétés de plantes résistantes existent-elles ?\nComment éviter la contamination du sol ?\nLes pratiques culturales peuvent-elles aider ?", "url": "https://questionsmedicales.fr/mesh/D010838?mesh_terms=Probability&page=275#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Phytophthora", "description": "Quels traitements sont efficaces contre Phytophthora ?\nLes fongicides sont-ils toujours efficaces ?\nComment améliorer la santé des plantes infectées ?\nPeut-on utiliser des méthodes biologiques ?\nQuel est le rôle de la rotation des cultures ?", "url": "https://questionsmedicales.fr/mesh/D010838?mesh_terms=Probability&page=275#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Phytophthora", "description": "Quelles complications peuvent survenir avec Phytophthora ?\nPhytophthora peut-elle affecter plusieurs cultures ?\nY a-t-il des impacts environnementaux ?\nLes pertes économiques sont-elles significatives ?\nComment les agriculteurs peuvent-ils faire face aux complications ?", "url": "https://questionsmedicales.fr/mesh/D010838?mesh_terms=Probability&page=275#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Phytophthora", "description": "Quels sont les principaux facteurs de risque ?\nLes conditions climatiques influencent-elles l'infection ?\nLes sols argileux sont-ils plus à risque ?\nLes pratiques agricoles intensives augmentent-elles le risque ?\nLes variétés sensibles sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D010838?mesh_terms=Probability&page=275#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection par Phytophthora ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'observation des symptômes et des tests de laboratoire." } }, { "@type": "Question", "name": "Quels tests de laboratoire sont utilisés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des cultures fongiques et des tests PCR peuvent être réalisés pour identifier Phytophthora." } }, { "@type": "Question", "name": "Quels symptômes indiquent une infection ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent le flétrissement, le jaunissement des feuilles et la pourriture des racines." } }, { "@type": "Question", "name": "Peut-on confondre Phytophthora avec d'autres champignons ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains symptômes peuvent être similaires à ceux d'autres maladies fongiques." } }, { "@type": "Question", "name": "Quel rôle joue l'humidité dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une humidité élevée favorise la prolifération de Phytophthora, ce qui aide au diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de Phytophthora ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent le flétrissement, le jaunissement et la décoloration des feuilles." } }, { "@type": "Question", "name": "Comment se manifeste la pourriture des racines ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "La pourriture des racines se manifeste par des racines noires et molles, souvent en décomposition." } }, { "@type": "Question", "name": "Les fruits peuvent-ils être affectés ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les fruits peuvent montrer des taches et une décomposition, surtout en conditions humides." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les plantes ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier selon l'espèce de plante hôte et les conditions environnementales." } }, { "@type": "Question", "name": "Y a-t-il des signes visibles sur le sol ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des zones de sol détrempé et des débris végétaux en décomposition peuvent être des signes." } }, { "@type": "Question", "name": "Comment prévenir les infections par Phytophthora ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut une bonne gestion de l'eau, des pratiques culturales et des variétés résistantes." } }, { "@type": "Question", "name": "Quel rôle joue le drainage dans la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Un bon drainage réduit l'humidité du sol, limitant ainsi la prolifération de Phytophthora." } }, { "@type": "Question", "name": "Les variétés de plantes résistantes existent-elles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines variétés de plantes sont développées pour être résistantes à Phytophthora." } }, { "@type": "Question", "name": "Comment éviter la contamination du sol ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'utilisation d'outils contaminés et pratiquer la désinfection du sol peut aider." } }, { "@type": "Question", "name": "Les pratiques culturales peuvent-elles aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des pratiques comme l'espacement des plantes et la gestion des résidus peuvent réduire les risques." } }, { "@type": "Question", "name": "Quels traitements sont efficaces contre Phytophthora ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des fongicides spécifiques et des pratiques culturales adaptées." } }, { "@type": "Question", "name": "Les fongicides sont-ils toujours efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité des fongicides peut varier selon la souche de Phytophthora et les conditions d'application." } }, { "@type": "Question", "name": "Comment améliorer la santé des plantes infectées ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Améliorer le drainage et réduire l'humidité peut aider à restaurer la santé des plantes." } }, { "@type": "Question", "name": "Peut-on utiliser des méthodes biologiques ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des agents biologiques comme des champignons antagonistes peuvent être utilisés." } }, { "@type": "Question", "name": "Quel est le rôle de la rotation des cultures ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La rotation des cultures aide à réduire l'accumulation de Phytophthora dans le sol." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Phytophthora ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la perte de rendement, la dégradation des cultures et des pertes économiques." } }, { "@type": "Question", "name": "Phytophthora peut-elle affecter plusieurs cultures ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Phytophthora peut infecter une large gamme de cultures, y compris les légumes et les fruits." } }, { "@type": "Question", "name": "Y a-t-il des impacts environnementaux ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les infections peuvent perturber les écosystèmes locaux et réduire la biodiversité." } }, { "@type": "Question", "name": "Les pertes économiques sont-elles significatives ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les pertes économiques dues à Phytophthora peuvent être considérables pour les agriculteurs." } }, { "@type": "Question", "name": "Comment les agriculteurs peuvent-ils faire face aux complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les agriculteurs peuvent adopter des stratégies de gestion intégrée pour minimiser les impacts." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'humidité élevée, le sol mal drainé et les pratiques culturales inadéquates." } }, { "@type": "Question", "name": "Les conditions climatiques influencent-elles l'infection ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des conditions climatiques humides favorisent la propagation de Phytophthora." } }, { "@type": "Question", "name": "Les sols argileux sont-ils plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les sols argileux retiennent plus d'eau, augmentant le risque d'infection par Phytophthora." } }, { "@type": "Question", "name": "Les pratiques agricoles intensives augmentent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les pratiques agricoles intensives peuvent accroître la vulnérabilité des cultures à Phytophthora." } }, { "@type": "Question", "name": "Les variétés sensibles sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la culture de variétés sensibles augmente le risque d'infection par Phytophthora." } } ] } ] }

Sources (2752 au total)

Long-term oral administration of Huaier granules improves survival outcomes in hepatocellular carcinoma patients within Milan criteria following microwave ablation: a propensity score matching and stabilized inverse probability weighting analysis.

This study aimed to elucidate the therapeutic effects of Huaier granules on hepatocellular carcinoma (HCC) within the Milan criteria in patients who underwent microwave ablation (MWA).... A total of 228 patients were included, with 97 in the Huaier group and 131 in the control group. We evaluated progression-free survival (PFS), overall survival (OS), and extrahepatic metastasis surviv... Following PSM, the 1-, 3-, and 5-year PFS rates in the Huaier and control groups were 83.5% vs 70.7%, 57.7% vs 42.6%, and 43.6% vs 31.9% (... Huaier granules can reduce the risk of recurrence and improve the OS of patients with HCC within the Milan criteria following MWA. Administering Huaier granules for over 6 months proved beneficial....

Cluster-Based Toxicity Estimation of Osteoradionecrosis via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification.

Given the limitations of extant models for normal tissue complication probability estimation for osteoradionecrosis (ORN) of the mandible, the purpose of this study was to enrich statistical inference... The analysis was conducted on retrospective data of 1,259 head and neck cancer (HNC) patients treated at the University of Texas MD Anderson Cancer Center between 2005 and 2015. The (structural) clust... The K-means clustering method identified six clusters among the DVHs. Based on the first five clusters, the dose-volume space was partitioned almost perfectly by the soft-margin SVM into distinct regi... This study presents an unsupervised-learning analysis of a large-scale data set to evaluate the risk of mandibular ORN among HNC patients. The results provide a visual risk-assessment tool (based on t...

Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).

The cardiovascular and renal outcomes of angiotensin-II receptor blocker (ARB) and angiotensin-converting enzyme inhibitor (ACEI) treatment are well-known; however, few studies have evaluated initiati... To emulate a target trial to evaluate the cognitive outcomes of initiating an ARB- vs ACEI-based antihypertensive regimen in individuals at risk for mild cognitive impairment (MCI) and probable dement... Active comparator, new-user observational cohort study design using data from the Systolic Blood Pressure Intervention Trial (SPRINT), conducted November 2010 through July 2018. Marginal cause-specifi... New users of ARB vs ACEI during the first 12 months of trial follow-up.... Composite of adjudicated amnestic MCI or PD.... Of 9361 participants, 727 and 1313 new users of an ARB or ACEI, respectively, with well-balanced baseline characteristics between medication exposure groups after inverse probability weighting (mean [... In this observational cohort study of US adults at high cardiovascular disease risk, there was no difference in the rate of amnestic MCI or PD among new users of an ARB compared with ACEI, although 95...

Imipenem/cilastatin/relebactam efficacy, safety and probability of target attainment in adults with hospital-acquired or ventilator-associated bacterial pneumonia among patients with baseline renal impairment, normal renal function, and augmented renal clearance.

To assess the relationship between renal function and efficacy/safety of imipenem/cilastatin/relebactam for the treatment of hospital-acquired/ventilator-associated pneumonia (HABP/VABP) from RESTORE-... Adults with HABP/VABP were randomized 1:1 to IV imipenem/cilastatin/relebactam 1.25 g or piperacillin/tazobactam 4.5 g every 6 h for 7-14 days. Initial doses were selected by CL... The modified ITT population comprised those with normal renal function (... Prescribing information-defined dose adjustments in participants with baseline RI and full dosing of imipenem/cilastatin/relebactam 1.25 g every 6 h for participants with normal renal function or augm...

Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China.

To identify less invasive and easily applicable serum cytokine-derived biomarkers which contribute to the diagnostic utility and risk assessment ability of the prostate health index (PHI) based multiv... Serum 45 cytokines screening was performed in a small training cohort consisting of 10 sera by Luminex liquid array-based multiplexed immunoassays and identified TRAIL and IL-10 as new biomarkers for ... TRAIL and IL-10 were identified as potential serum biomarkers for AG PCa detection by the result of multi-cytokines screening in the univariate analysis, while multivariable logistic regression confir... We suggest a significant advantage for the PHI-based multivariate combinations of serum TRAIL and IL-10 comparing to PHI or other serum-derived biomarkers alone in the detection and risk stratificatio...

Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.

Switching from intravenous antibiotic therapy to oral antibiotic therapy among neonates is not yet practised in high-income settings due to uncertainties about exposure and safety. We aimed to assess ... In this multicentre, randomised, open-label, non-inferiority trial, patients were recruited at 17 hospitals in the Netherlands. Neonates (postmenstrual age ≥35 weeks, postnatal age 0-28 days, bodyweig... Between Feb 8, 2018 and May 12, 2021, 510 neonates were randomly assigned (n=255 oral amoxicillin-clavulanic group; n=255 intravenous antibiotic group). After excluding those who withdrew consent (n=4... An early intravenous-to-oral antibiotic switch with amoxicillin-clavulanic acid is non-inferior to a full course of intravenous antibiotics in neonates with probable bacterial infection and is not ass... The Netherlands Organization for Health Research and Development, Innovatiefonds Zorgverzekeraars, and the Sophia Foundation for Scientific Research....

'I probably wouldn't want to talk about anything too personal': A qualitative exploration of how issues of privacy, confidentiality and surveillance in the home impact on access and engagement with online services and spaces for care-experienced young people.

This paper draws on a qualitative interview-based study that explored online mental health and wellbeing interventions and services for care-experienced young people. The study involved young people (...

Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).

The risk and survival of patients with non-small cell lung cancer (NSCLC) with pre-existing autoimmune disorders (AIDs) receiving immune checkpoint blockade (ICB) therapy have not been clearly establi... This multi-institutional, retrospective cohort study was conducted in collaboration with 20 centers in Japan.... In total, 229 patients with advanced or recurrent NSCLC and pre-existing AID, with or without ICB treatment from January 2010-February 2020, were included and analyzed. Among 69 patients who received ... These findings revealed a novel risk factor for AID flares following ICB treatment, that is the diagnosis of NSCLC within 1 year of AID diagnosis, and showed that ICBs may improve survival in this pop...